This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2024 Apr 1;10(4):433-434.

doi: 10.1001/jamaoncol.2023.5855.

Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical Practice

Elad Sharon^{1

2}

Affiliations

PMID: 38451519
DOI: 10.1001/jamaoncol.2023.5855

Editorial

Advancing Truth in Oncology by Complementing Clinical Trials With Evidence From Clinical Practice

Elad Sharon. JAMA Oncol. 2024.

. 2024 Apr 1;10(4):433-434.

doi: 10.1001/jamaoncol.2023.5855.

Author

Elad Sharon^{1

2}

Affiliations

¹ Dana-Farber Cancer Institute, Boston, Massachusetts.
² Harvard Medical School, Boston, Massachusetts.

PMID: 38451519
DOI: 10.1001/jamaoncol.2023.5855

No abstract available

PubMed Disclaimer

Comment on

Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer.
Tsukita Y, Tozuka T, Kushiro K, Hosokawa S, Sumi T, Uematsu M, Honjo O, Yamaguchi O, Asao T, Sugisaka J, Saito G, Shiihara J, Morita R, Katakura S, Yasuda T, Hisakane K, Miyauchi E, Morita S, Kobayashi K, Asahina H. Tsukita Y, et al. JAMA Oncol. 2024 Apr 1;10(4):439-447. doi: 10.1001/jamaoncol.2023.6277. JAMA Oncol. 2024. PMID: 38451530 Free PMC article.

References

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information